DEVELOPMENT OF THYROIDAL SUPPRESSION BY TRIIODOTHYRONINE DURING 6 MONTHS TREATMENT OF THYROTOXICOSIS WITH ANTITHYROID DRUGS

被引：38
|
作者：
ALEXANDER, WD
HARDEN, RM
SHIMMINS, J
MCLARTY, D
MCGILL, P
机构：
来源：
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM | 1967年 / 27卷 / 12期
关键词：
D O I：
10.1210/jcem-27-12-1682
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1682 / +
页数：1
相关论文
共 50 条
  • [31] Audit of long-term treatment outcomes of thyrotoxicosis in a single-centre virtual clinic: The utility of long-term antithyroid drugs
    Levy, Miles J.
    Reddy, Narendra
    Price, David
    Bhake, Ragini
    Bremner, Emma
    Barrowcliffe, Mary
    Kieffer, Veronica
    Robinson, Carole
    Zaccardi, Francesco
    Howlett, Trevor A.
    CLINICAL ENDOCRINOLOGY, 2022, 97 (05) : 643 - 653
  • [32] Antithyroid drugs used in the treatment of hyperthyroidism during breast feeding. An update and new perspectives
    Spyros Karras
    Themistoklis Tzotzas
    Gerasimos E. Krassas
    Hormones, 2009, 8 : 254 - 257
  • [33] Antithyroid drugs used in the treatment of hyperthyroidism during breast feeding. An update and new perspectives
    Karras, Spyros
    Tzotzas, Themistoklis
    Krassas, Gerasimos E.
    HORMONES-INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM, 2009, 8 (04): : 254 - 257
  • [34] DEVELOPMENT OF MANIPULATION IN CAPUCHIN MONKEYS DURING THE FIRST 6 MONTHS
    ADAMSCURTIS, LE
    FRAGASZY, DM
    DEVELOPMENTAL PSYCHOBIOLOGY, 1994, 27 (02) : 123 - 136
  • [35] Decrease of interleukin 6 during the first 12 months is a prognostic marker for clinical outcome during 36 months treatment with disease-modifying anti-rheumatic drugs
    Straub, RH
    Müller-Ladner, U
    Lichtinger, T
    Schölmerich, J
    Menninger, H
    Lang, B
    BRITISH JOURNAL OF RHEUMATOLOGY, 1997, 36 (12): : 1298 - 1303
  • [36] Use of clinical and laboratory data for prediction of Graves' disease 1-year remission after 12 months of treatment with antithyroid drugs
    Peixoto, Maria Claudia
    Buescu, Alexandru
    Goncalves, M. Rocio Bencke
    Albernaz, Marta de Souza
    Coeli, Claudia Medina
    Vaisman, Mario
    ENDOCRINOLOGIST, 2008, 18 (01) : 25 - 29
  • [37] 2 CASES OF GRAVES DISEASE WITH SIGNS OF A PYRAMIDAL LESION - IMPROVEMENT IN NEUROLOGIC SIGNS DURING TREATMENT WITH ANTITHYROID DRUGS
    RAVERA, JJ
    CERVINO, JM
    FERNANDEZ, G
    FORCADE, AF
    MALOSETTI, H
    MUXI, F
    MAGGIOLO, J
    FOURNIER, JCM
    RAWAK, F
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1960, 20 (06) : 876 - 880
  • [38] 3 PATIENTS WHO SPONTANEOUSLY DEVELOPED PERSISTENT HYPOTHYROIDISM DURING OR FOLLOWING TREATMENT WITH ANTITHYROID DRUGS FOR GRAVES HYPERTHYROIDISM
    SHIGEMASA, C
    MITANI, Y
    TANIGUCHI, S
    ADACHI, T
    UETA, Y
    URABE, K
    MIYAZAKI, S
    TANAKA, T
    YOSHIDA, A
    MASHIBA, H
    ARCHIVES OF INTERNAL MEDICINE, 1990, 150 (05) : 1105 - 1109
  • [39] Motor development during the first 6 months: The case of Brazilian infants
    Santos, DCC
    Gabbard, C
    Goncalves, VMG
    INFANT AND CHILD DEVELOPMENT, 2000, 9 (03) : 161 - 166
  • [40] Development of prediction model for alanine transaminase elevations during the first 6 months of conventional synthetic DMARD treatment
    Kuusalo, Laura
    Venalainen, Mikko S.
    Kirjala, Heidi
    Saranpaa, Sofia
    Elo, Laura L. L.
    Pirila, Laura
    SCIENTIFIC REPORTS, 2023, 13 (01)
12345